Recent findings shed light on why younger children exhibit fewer severe COVID-19 symptoms compared to…
Browsing: National Institute of Allergy and Infectious Diseases
The National Institute of Allergy and Infectious Diseases (NIAID) is a part of the U.S. National Institutes of Health (NIH) and is primarily responsible for conducting and supporting research to study the causes, treatments, and prevention of infectious and immune-mediated diseases. Established in 1955, NIAID plays a crucial role in responding to emerging public health threats such as the HIV/AIDS epidemic, influenza, tuberculosis, malaria, and more recently, the COVID-19 pandemic. The institute supports a broad range of research from basic science investigating the pathogenesis of disease to clinical trials and vaccine development. NIAID also provides funding to a network of research institutions worldwide. Directed by Dr. Anthony Fauci since 1984, NIAID has been instrumental in promoting better health outcomes and advancements in understanding immune system function and management of infectious diseases. The research conducted and supported by NIAID is pivotal in developing strategies to control and prevent diseases that threaten millions of lives globally.
A virtual workshop in November 2022 highlighted the importance of developing mucosal vaccines for SARS-CoV-2…
The thermostable TB vaccine ID93+GLA-SE demonstrated robust immune responses and safety, offering a practical solution…
NIH Scientists Find That IV Administration Improves Tumor-Fighting Action An experimental therapeutic cancer vaccine induced…
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of…
Study Includes Multiple Variant Vaccines Adults interested in joining this study should visit ClinicalTrials.gov and…
Phase 1 Study Is Among First to Examine mRNA Technology for HIV. The National Institute…
Herd immunity against COVID-19 is unlikely, but widespread vaccination, treatments, and testing can allow life…
Researchers from the National Institute of Allergy and Infectious Diseases (NIAID) are conducting a clinical…
NIAID-sponsored study assessed dose in adults fully vaccinated with any EUA or approved COVID-19 vaccine.…
An NIH-funded study on peanut oral immunotherapy showed promising results in desensitizing and inducing remission…
Cabotegravir, the first injectable HIV prevention drug, has won FDA approval. Taken every two months,…
Experts warn that novel coronaviruses will continue to emerge from bats and other animal reservoirs,…
NIH Scientists Developed Vaccine Platform An experimental HIV vaccine based on mRNA—the same platform technology…
SARS-CoV-2 Prevents Lung Tissue Repair, Regeneration Lung autopsy and plasma samples from people who died…
Different Mechanisms Suppressed the Virus in Each Person Research led by scientists at the National…
A clinical trial has found that treatment with the immunomodulator interferon beta-1a plus the antiviral…
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of…